Medicine recalls
|
| |
| The United Kingdom: Class 3 Medicines Recall: Theramex HQ UK Ltd, Evorel Sequi |
| |
Medicines and Healthcare products Regulatory Agency (MHRA) announces that Theramex has informed the MHRA that some cartons of Evorel Sequi (batch number: 6137001) contain the incorrect combination of patches.
Each pack of Evorel Sequi contains eight patches; four Evorel 50 patches (containing estradiol only) and four Evorel Conti patches (containing estradiol and norethisterone).
An error at the packaging site means that a limited number of packs have the incorrect combination of Evorel 50 and Evorel Conti patches. Only the batch listed in this notification is affected. The remainder of the batch is being recalled as a precautionary measure. The batch is comprised of 112,728 packs. So far 19 packs have been confirmed to contain the incorrect combination and the investigation has concluded that the issue is limited to a small number of packs only.
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/class-3-medicines-recall-theramex-hq-uk-ltd-evorel-sequi-el-24-a-slash-41
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by MHRA, and was posted on the Drug Office website on 6 Sep 2023.
Ends/Friday, Sep 13, 2024
Issued at HKT 16:30
|
| |
|
